Related Experiment Videos
Animal models of inherited complement deficiency
1Department of Rheumatology, Nevill Hall Hospital, Brecon Road, Abergavenny, NP7 7EG, UK. lintons@doctors.org.uk
Molecular Biotechnology
|July 27, 2001
Summary
Animal models with complement deficiencies, like C3 and C6, are crucial for understanding inflammation and infection. These studies reveal the complement system
Area of Science:
- Immunology
- Molecular Biology
- Pathogenesis Research
Background:
- Natural deficiencies in complement components have been identified across various animal species.
- These deficiencies are often characterized at the molecular level, providing insights into complement system function.
- Previous research has utilized murine strains deficient in complement component C5.
Purpose of the Study:
- To explore the role of specific complement factors and pathways in disease pathogenesis using naturally deficient animal models.
- To investigate the pathogenetic role of the terminal membrane attack complex (MAC) in inflammatory conditions.
- To advance understanding of the activated complement system in experimental inflammatory diseases.
Main Methods:
- Characterization of natural complement component deficiencies in various animal species.
- Utilizing animal models with deficiencies in early complement factors, C3, and C6.
- Integrating findings from naturally deficient strains with studies on knockout animals.
Main Results:
- Deficiencies in early complement factors impair immune response, potentially due to defective immune complex processing.
- Complete C3 deficiency significantly increases susceptibility to infection and renal disease in affected animals.
- C6 deficiency studies implicate the MAC in inflammatory insults like reperfusion injury, glomerular damage, and xenograft rejection.
Conclusions:
- Naturally deficient animal models are invaluable tools for dissecting complement-mediated inflammation and infection.
- The terminal MAC plays a significant role in various inflammatory disease processes.
- Continued research in these models holds potential for developing novel therapeutic strategies for human diseases.